Check-Cap (MBAI) Net Cash Flow Growth (1y) (2015 - 2024)
Check-Cap (MBAI) Net Cash Flow Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -260.86% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -86.40% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -115.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 73.93% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -441.96% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -424.43% |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -448.78% |
| Dec 31, 2023 | 516.58% |
| Sep 30, 2023 | 453.94% |
| Jun 30, 2023 | 89.95% |
| Mar 31, 2023 | -6.78% |
| Dec 31, 2022 | -41.47% |
| Sep 30, 2022 | -106.07% |
| Jun 30, 2022 | -500.58% |
| Mar 31, 2022 | -4.58% |
| Dec 31, 2021 | 81.40% |
| Sep 30, 2021 | 1,950.49% |
| Jun 30, 2021 | -467.65% |
| Mar 31, 2021 | 2,491.25% |
| Dec 31, 2020 | -4,219.58% |
| Sep 30, 2020 | -69.38% |
| Jun 30, 2020 | 404.99% |
| Mar 31, 2020 | -70.07% |
| Dec 31, 2019 | 19.42% |
| Sep 30, 2019 | 18.34% |
| Jun 30, 2019 | 102.71% |